Combination pegylated interferon alpha-2b and ribavirin in transplant patients with recurrent hepatitis C infection: A preliminary report.

被引：0
|
作者：
Vargas, HE [1 ]
Rosati, MJ [1 ]
Douglas, DD [1 ]
Harrison, ME [1 ]
Mulligan, DC [1 ]
Moss, AA [1 ]
Rakela, J [1 ]
Balan, V [1 ]
机构：
[1] Mayo Clin, Phoenix, AZ USA
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
939
引用
收藏
页码：407A / 407A
页数：1
相关论文
共 50 条
  • [41] A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
    You, Byung Chul
    Kim, Young Seok
    Kim, Hun il
    Kim, Se Hun
    Park, Seung Sik
    Seo, Yu Ri
    Kim, Sang Gyune
    Lee, Se Whan
    Kim, Hong Soo
    Jeong, Soung Won
    Jang, Jae Young
    Kim, Boo Sung
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2012, 18 (03) : 272 - 278
  • [42] Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection
    Sulkowski, MS
    Wasserman, R
    Brooks, L
    Ball, L
    Gish, R
    [J]. JOURNAL OF VIRAL HEPATITIS, 2004, 11 (03) : 243 - 250
  • [43] Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients
    El-Zayadi, A
    Selim, O
    Haddad, S
    Simmonds, P
    Hamdy, H
    Badran, HM
    Shawky, S
    [J]. ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (06): : 472 - 475
  • [44] Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients
    Crespo, M.
    Sauleda, S.
    Esteban, J. I.
    Juarez, A.
    Ribera, E.
    Andreu, A. L.
    Falco, V.
    Quer, J.
    Ocana, I.
    Ruiz, I.
    Buti, M.
    Pahissa, A.
    Esteban, R.
    Guardia, J.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2007, 14 (04) : 228 - 238
  • [45] Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C
    Poynard, T
    [J]. GUT, 2003, 52 (10) : 1532 - 1532
  • [46] Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis
    Naoki Hiramatsu
    Masayuki Kurosaki
    Naoya Sakamoto
    Manabu Iwasaki
    Minoru Sakamoto
    Yoshiyuki Suzuki
    Fuminaka Sugauchi
    Akihiro Tamori
    Sei Kakinnuma
    Kentaro Matsuura
    Namiki Izumi
    [J]. Journal of Gastroenterology, 2011, 46
  • [47] Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis
    Hiramatsu, Naoki
    Kurosaki, Masayuki
    Sakamoto, Naoya
    Iwasaki, Manabu
    Sakamoto, Minoru
    Suzuki, Yoshiyuki
    Sugauchi, Fuminaka
    Tamori, Akihiro
    Kakinnuma, Sei
    Matsuura, Kentaro
    Izumi, Namiki
    [J]. JOURNAL OF GASTROENTEROLOGY, 2011, 46 (09) : 1111 - 1119
  • [48] Results of combination treatment with pegylated interferon and ribavirin in cirrhotic patients with hepatitis C infection
    Höroldt, B
    Haydon, G
    O'Donnell, K
    Dudley, T
    Nightingale, P
    Mutimer, D
    [J]. GUT, 2006, 55 : A43 - A43
  • [49] Pegylated Interferon Alpha-2B for the Management of Patients With Chronic Hepatitis Delta
    Gheorghe, Liana
    Iacab, Speranta
    Simionov, Iulia I.
    Vadan, Roxawa
    Constantinescu, Ileana
    Sporea, Ioan
    Grigotescu, Mircea D.
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S454 - S454
  • [50] Results of combination treatment with pegylated interferon and ribavirin in cirrhotic patients with hepatitis C infection
    Horoldt, Barbara
    Haydon, Geoffrey
    O'Donnell, Katrina
    Dudley, Tracey
    Nightingale, Peter
    Mutimer, David
    [J]. LIVER INTERNATIONAL, 2006, 26 (06) : 650 - 659
12345